FDA Reassesses BHA Safety Amid Carcinogen Concerns
Rapid Read Rapid Read

FDA Reassesses BHA Safety Amid Carcinogen Concerns

What's Happening? The U.S. Food and Drug Administration (FDA) is currently reassessing the safety of butylated hydroxyanisole (BHA), a chemical preservative widely used in food products. This reassessment comes as the FDA issues a Request for Information (RFI) to gather data on BHA's use and safety.
Summarized by AI
AI Generated
This may include content generated using AI tools. Glance teams are making active and commercially reasonable efforts to moderate all AI generated content. Glance moderation processes are improving however our processes are carried out on a best-effort basis and may not be exhaustive in nature. Glance encourage our users to consume the content judiciously and rely on their own research for accuracy of facts. Glance maintains that all AI generated content here is for entertainment purposes only.